Da kommt heute noch eine interessante Info rein:
http://investor.firstsolar.com…tronics-warranty-services
Hier sollte es doch möglich sein, endlich über die 70.- zu springen. Da sind Q4-Zahlen geplant auf den 27. Februar 2018. Ich beobachte den Kurs und den Chart.
Wunderbar, gewaltig, seit dem 23. Dezember 2017 hat sich der Kurs verdoppelt und steht nun bei ca. C$ 42.-/43.-.
Ich stehe nun mal an die Seitenlinie. Wiedereinstieg geplant. Man wird sehen.
Da sehe ich doch noch, dass Infos kommen am Donnerstag. Ich bin gespannt:
Dear investors,
You are cordially invited to a telephone conference with Partners Group’s senior management on 11 January 2018 at 9am CET in which they will provide information on the firm's estimated assets under management as of 31 December 2017. A press release will be published ahead of the call at 7am CET. Partners Group's complete annual financial results will be announced on 20 March 2018.
Should you be interested in participating in the telephone conference or listening to the recording, please reply to this e-mail and my colleague Milevka Grceva will provide you with the necessary access information in due course.
We look forward to hearing from you.
Kind regards,
Philip
Philip Sauer
Co-Head Group Finance & Corporate Development
Partners Group
Zugerstrasse 57
6341 Baar-Zug
Switzerland
T +41 41 784 66 60
F +41 41 784 60 01
philip.sauer@partnersgroup.com
www.partnersgroup.com
Get the latest Partners Group updates on Linkedin, follow us here:
( Lorenz, betr. Aurora, Kanada. Danke für den Hinweis von heute 16:21h, ich sehe dann da eher Kurs-Stagnation).
Info:
News provided byCanopy Growth Corporation
07:11 ET
SMITHS FALLS, ON, Jan. 5, 2018 /CNW/ - In response to news out of the United States Department of Justice yesterday morning regarding federal cannabis laws in the United States and further to press releases issued Oct 17, 2017 and Aug. 4, 2017, Canopy Growth Corporation (TSX: WEED) ("Canopy Growth" or the "Company") wishes to reiterate its commitment to only conducting business in jurisdictions where that conduct is federally legal and otherwise in compliance with all applicable laws.
Canopy Growth does not and will not conduct business in any jurisdiction unless it is federally permissible. Conducting activities which are federally illegal, or investing in companies which do, exposes the Company to increased risk of prosecution. Such activities would compromise Canopy Growth's ability to operate freely, and could jeopardize the Company's listing eligibility on major securities exchanges now and in the future, and limit access to capital from reputable US-based funds and world-class partners.
"We want to make our position as clear as possible: While Canopy does not support continued cannabis prohibition, it is Management's view that confusion surrounding federal cannabis laws in the United States presents advantages for Canopy Growth, not risks. We are confident in our position because we have exclusively focused on ethical, responsible and legal cannabis opportunities across the globe and not in the United States," said Bruce Linton, Chairman & CEO, Canopy Growth. "We want to assure our shareholders that they are not being exposed to undue risk."
Here's to Future Growth.
About Canopy Growth Corporation
Canopy Growth is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time.
Canopy Growth has established partnerships with leading sector names including cannabis icon Snoop Dogg, breeding legends DNA Genetics and Green House seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates seven cannabis production sites with over 665,000 square feet of production capacity, including over 500,000 square feet of GMP-certified production space. The Company has operations in seven countries across four continents. The Company is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public's understanding of cannabis, and through its partly owned subsidiary, Canopy Health Innovations, has devoted millions of dollars toward cutting edge, commercializable research and IP development. Through partly owned subsidiary Canopy Rivers Corporation, the Company is providing resources and investment to new market entrants and building a portfolio of stable investments in the sector. From our historic public listing to our continued international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth. For more information visit www.canopygrowth.com
Notice Regarding Forward Looking Statements
This news release contains forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Canopy Growth Corporation, its subsidiaries, or its affiliates to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Examples of such statements include future operational and production capacity, the impact of enhanced infrastructure and production capabilities, and forecasted available product selection. The forward-looking statements included in this news release are made as of the date of this news release and Canopy Growth Corporation does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.
Neither the TSX Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE Canopy Growth Corporation
[Blocked Image: https://rt.newswire.ca/rt.gif?NewsItemId=C1655&Transmission_Id=201801050711CANADANWCANADAPR_C1655&DateId=20180105]
For further information: Jordan Sinclair, Director of Communications, Jordan@tweed.com, 613-769-4196; Investor Relations: Tyler Burns, Tyler.burns@canopygrowth.com, 855-558-9333 ex 122; Director: Bruce Linton, tmx@tweed.com
Related Links
Ich habe auch noch gesucht und keinen News-Alert gefunden bei Aurora. Eigentlich schade. Man kann ja mal etwas hinschauen dort.-
Ich habe noch heutige News von CGC
Canopy Growth forms JV for greenhouse-grown cannabis
Reuters Staff
Dec 18 (Reuters) - Canada’s Canopy Growth Corp said it would form a joint venture with privately owned Canopy Rivers Corp and Quebec-based tomato producer Les Serres Stéphane Bertrand to grow cannabis in a tomato greenhouse.
Canopy Growth will give Bertrand C$2.75 million ($2.14 million) worth of shares and Canopy Rivers will contribute C$15 million in cash.
Bertrand has 700,000 square feet of modern greenhouse, which the companies say would begin producing cannabis by May.
Tomato and pepper are the most common choices to convert to weed as they have similar growth requirements and are also grown in greenhouses.
Canada is on track to legalize recreational marijuana by July and the government’s proposed law also permits adults to grow up to four marijuana plants at home.
However, the Quebec government has said it will not allow residents of the province to grow their own marijuana.
Canopy Growth and Canopy Rivers together will own 66.7 percent of the new company and Bertrand will own the remaining.
$1 = C$1.29 Reporting by Taenaz Shakir in Bengaluru; Editing by Maju Samuel
Our Standards:The Thomson Reuters Trust Principles.
Ausführlicher:
http://www.newswire.ca/news-re…production-664923733.html
und auch von heute:
Auch ich bringe noch etwas gute News zum Wochenschluss: *smile* *dirol*
https://www.reuters.com/articl…nd-labrador-idUSL3N1O84LA
News provided byCanopy Growth Corporation
08:12 ET
Share this article
ST. JOHN'S & SMITHS FALLS, ON, Dec. 8, 2017 /CNW/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") along with representatives from the Province of Newfoundland and Labrador today are pleased to announce that the Company has entered into a supply and production agreement, the largest provincial cannabis supply agreement announced to date, securing a regulated supply of cannabis for Newfoundlanders and Labradorians heading into the legal adult access market.
-->
[Blocked Image: https://mma.prnewswire.com/media/617372/Canopy_Growth_Corporation_Newfoundland___Labrador_and_Canopy_Gro.jpg?w=800]
Tweed, DNA Genetics, and Leafs By Snoop are some of the many brands sold under Canopy Growth's portfolio (CNW Group/Canopy Growth Corporation)
-->
Canopy Growth will supply 8,000 kg of high quality cannabis products annually for the first two years of the deal. Under the terms of the agreement, Canopy Growth will establish a new production facility in Newfoundland and Labrador capable of producing 12,000 kg per year, bringing 145 jobs in an emerging sector and major capital investment to the region. Site locations are being evaluated to house what could be the first licensed production facility in the province.
"This agreement today with an internationally recognized producer not only guarantees a safe supply of cannabis for Newfoundland and Labrador before the federally imposed July 2018 implementation date, but also results in the creation of 145 new jobs in our province," said the Honourable Christopher Mitchelmore, Minister of Tourism, Culture, Industry and Innovation, Newfoundland and Labrador. "We will also use this as a framework for other agreements related to cannabis supply and production. Our vision is for an industry which leads to production, job creation, supply chain development and research and development in this province."
"Canopy's operations will soon stretch from Coast to Coast, with locations now planned in seven provinces including Newfoundland and Labrador," said Bruce Linton, Chairman & CEO, Canopy Growth. "Wherever we operate we look for ways to integrate ourselves into the local community to make sure we are giving back to the communities we call home."
Canopy's wholly-owned subsidiary, Tweed Inc. ("Tweed") will also be eligible to apply to operate four new retail locations in the province. This would be a major milestone for Tweed, a leading brand in today's cannabis industry. These four licences would represent the first announced privately owned and operated legal cannabis retail locations in the country. Site scouting is underway, with two locations possible on the Avalon Peninsula, one west of the Avalon Peninsula, and another at the future production site. Canopy Growth and Tweed are also seeking retail locations at their production facilities in other provinces, a common practice for breweries and wineries across Canada.
Mr. Linton continued, "The Newfoundland and Labrador retail framework will allow us to take our existing e-commerce business and well-recognized house of brands including Tweed, DNA Genetics, Leafs By Snoop, and our CraftGrow program, and present that pride and dedication in a "brick and mortar" retail environment. I want to congratulate the Government of Newfoundland and Labrador for choosing a retail model that encourages local growth and a made-at-home experience, while balancing private and public involvement."
Tweed has a long track record of responsible cannabis sales as a medical producer and has partnered with organizations like MADD Canada and Parent Action on Drugs to ensure Canada exits prohibition in a responsible way. The Company looks forward to establishing welcoming and warm retail spaces that prioritize top-notch customer service and product education, supported by Canada's largest cannabis production platform and a wide number of CraftGrow partnerships to bring cannabis of all forms and sizes to the people of Newfoundland & Labrador......
Quelle:
Ja eben:
ZK: *dirol*
https://de.wikipedia.org/wiki/…g_der_Vereinigten_Staaten
Ja durchaus. Schade, sind es OTC-Titel, sonst würde es mich eher interessieren. Solche die in USA auch kotiert sind, interessieren mich für diese Branche allerdings nicht. Andere sind eventuell interessiert.-
Zu CGC, hier noch eine Meldung von Bedeutung, dat. von gestern:
2017-11-28 07:15 ET - News Release
See News Release (C-WEED) Canopy Growth Corp
Mr. Mark Zekulin of Canopy reports
CANOPY GROWTH ADDS MANITOBA-BASED LICENSED PRODUCER DELTA 9 TO THE CRAFTGROW FAMILY
Canopy Growth Corp. has entered into a distribution agreement with Winnipeg-based Delta 9 Cannabis Inc. Delta 9 will offer its well-established cannabis products through Canopy Growth's curated CraftGrow line via Tweed Main Street's on-line store, alongside other high-quality cannabis varieties grown by a diverse set of producers.
Delta 9 was founded in 2012, and quickly became the fourth fully licensed producer and distributor of medical cannabis in Canada. Currently operating an 80,000-square-foot production facility in east Winnipeg, Delta 9 is focused on growing small-batch, hand-trimmed medical cannabis strains in its innovative, self-designed grow pod systems. As Manitoba has recently unveiled its proposed cannabis distribution model, which includes private sales, Delta 9 will work with Canopy Growth to continue to serve the local market with consistent high-quality standardized cannabis products, while gaining access to consumers across the country through Canopy Growth's on-line marketplace.
"We recognize the varied needs of our patients and through the CraftGrow program we aim to bring them the highest-quality products from a variety of producers that each bring a unique offering forward," said Mark Zekulin, president of Canopy Growth. "This is the ninth participant in the CraftGrow program, and we are particularly excited to see one of the earliest established producers in our sector come on board. We want to promote the value of our platform approach and welcoming Delta 9's products to our shop speaks volumes to the CraftGrow program's potential."
Canopy Growth's CraftGrow line aims to build an ecosystem of high-quality cannabis options for patients across the country. As the newest member of the CraftGrow family, Delta 9 will gain direct access to Canopy Growth's extensive operational, distribution, marketing and sales infrastructure through the Tweed Main Street on-line marketplace where a gram is shipped on average every four seconds. Its sector-leading fulfilment centre then ships these orders to customers all across the country.
"Our company is excited to further our growing partnership with Canopy Growth," said Delta 9 chief executive officer John Arbuthnot. "We are already working closely on a project to jointly serve the growing market in Manitoba; this project brings Delta 9's craft grown cannabis products to a wider national audience through Canopy's well-established CraftGrow network."
Canopy Growth is committed to growing a thriving cannabis marketplace that offers diversity of producers and products to valuable customers. The CraftGrow program is an integral part of an effective cannabis ecosystem, and the addition of Delta 9 strengthens the program and supports continuing success.
About Canopy Growth Corp.
Canopy Growth is a world-leading diversified cannabis company, offering distinct brands and curated cannabis varieties in dried, oil and capsule forms. Through its wholly owned subsidiaries, Canopy Growth operates numerous state-of-the-art production facilities with over 700,000 square feet of licensed production, over 500,000 square feet of which are GMP-certified. Looking forward to 2018, Canopy Growth and its affiliates are developing a production platform that will represent 3.2 million square feet of indoor and greenhouse production capacity, all operated with world-leading production, quality assurance procedures, value-add postprocessing, research and testing. Canopy Growth has established partnerships with leading sector names in Canada and abroad, with interests and operations spanning seven countries and four continents.
About Delta 9 Cannabis Inc.
Delta 9's wholly owned subsidiary, Delta 9 Bio-Tech, is a licensed producer of medical marijuana pursuant to Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR) and operates an 80,000-square-foot, expandable, state-of-the-art production facility in Winnipeg, Man., Canada.
We seek Safe Harbor.
© 2017 Canjex Publishing Ltd. All rights reserved.
im Aufwind. Hier sollte man mal reinhören in der kommenden Woche.
Info von heute:
@ shanik82
Ja, der Kurs ist auch etrem tief, wäre fast was zum aufsammeln. Zurzeit möchte ich aber nicht dort.
Bei CGC war 'Gewinne mitnehmen' schon ok, man sollte dann den Wiedereinstieg nicht verpassen... *blum3**dirol*
Canopy Growth, Organa Brands, Green House Seeds Collaborate to bring New Products to Canadian Market and Beyond
SMITHS FALLS, ON, DENVER and AMSTERDAM, Nov. 17, 2017 /CNW/ - Green House Holdings North America Inc. ("Green House"), its affiliate in the Netherlands, GHSC Trading B.V., National Concessions Group Inc. ("Organa Brands") and Canopy Growth Corporation ("Canopy Growth" or "the Company") (TSX: WEED), together three of the most storied and successful global cannabis businesses are pleased to announce the planned creation of a collaborative joint venture (the "JV").
To establish the JV, Canopy Growth will allocate a portion of ownership in ACMPR-licensed Agripharm Corp. ("Agripharm"), a 20,000 sq. ft. indoor growing facility located in Creemore, Ontario, to its new partners. Canopy Growth will retain 40% ownership of Agripharm, while Green House and Organa Brands will own 40% and 20%, respectively, of Agripharm. In exchange for the issuance of shares, Green House and Organa Brands have granted an exclusive, royalty-free licence in Canada to certain proprietary technology, trademarks, genetics, know-how and other intellectual property to Agripharm, subject to compliance with applicable law.
The JV will create a new Canadian home-base for Green House and Organa Brands where they will work together with Canopy Growth to produce cannabis products for the Canadian market. Pursuant to the JV, the Company has the right to purchase all of the cannabis products produced by Agripharm to be exclusively distributed via Canopy Growth's national channels, subject to limited exceptions. In addition, the Company will sublicense the proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm in order to ensure that Canopy Growth is able to satisfy consumer demand across Canada for the suite of Green House and Organa Brands products.
Although Agripharm is focused on the Canadian market, Canopy Growth, Green House, Organa Brands and their respective affiliates will also explore other federally-legal international opportunities as they arise, including with respect to medical research and development opportunities, product distribution platforms, and brick-and-mortar retail locations. Agripharm will not conduct any business in the United States.
"Our business has separated itself from the competition by focusing on brands and products that resonate with people but also because we've found creative ways to collaborate with like-minded businesses to increase the breadth of our product offering," said Mark Zekulin, President, Canopy Growth. "From world-class breeders like our partners DNA Genetics and now Green House Seeds, to sector innovators like Organa Brands, to cultural icons like Snoop Dogg, we work with the best in order to bring the best possible cannabis forward to our customers."
The JV is expected to close on or about December 1, 2017. Operationally, Canopy Growth will transfer oversight to its new collaborators who will operate a pristine licensed facility with modular growing rooms designed to produce only the very best cannabis flowers. Green House will oversee day-to-day operations and bring their own expertise into cultivation, while Organa will implement world-class extraction functions as new and novel value-add products become part of the regulatory environment. Canopy Rivers Corporation, a partly-owned subsidiary of Canopy Growth, has also entered into an agreement to provide the JV with up to $20 million in funding for the expansion of the facility in exchange for ongoing royalty payments and a warrant to acquire up to 4% of the issued and outstanding common shares.
"For 30 years Green House Brands has been at the forefront of cannabis legalization by advocating for its normalization and expansion into new territories," said Arjan Roskam, the founder of Green House Brands. "We're now operating in four continents (Europe, Africa, South America and North America) and thanks to this new partnership with these two prominent market leaders in the industry, Canopy and Organa Brands, we will create even more opportunities globally to help the world access cannabis in a legal way. This epic move will allow us to maintain our position as a world leader in genetics and cannabis retail, while alerting the cannabis consumer that we will continue striving to make cannabis available worldwide for all medicinal and recreational consumers one day."
Canopy Growth, Green House, and Organa Brands each bring a unique set of skills that are strategically complementary to one another. Canopy Growth has built an online distribution platform that touches every province and territory in Canada as well as 7 international markets; Green House is a genetic leader that has bred some of the world's most sought-after strains; and Organa Brands is an extract product innovator. Together, the JV is positioned to take sought after genetics, insert those genetics into consumer-friendly ingestion formats, and put them on stores shelves across the country, and abroad.
"We are incredibly excited about this new partnership - since the inception of Organa Brands, one of the key tenets of our business has been forming smart partnerships with mutually beneficial results. Working with Canopy and Green House has been a surreal moment as we continue to fully recognize the impact of what this deal means for the industry as a whole" said Organa Brands Co-Founder, Jeremy Heidl. "We couldn't have asked for better partners in Canada and beyond- this new global partnership will prove to be a defining moment for all parties involved."
Cassels Brock & Blackwell LLP acted as legal counsel to Canopy Growth with respect to the JV, Dentons Canada LLP acted as legal counsel to Green House, and Stikeman Elliott LLP acted as legal counsel to Organa Brands.
For more information on this new partnership click here.
Here's to Future Growth.
About Canopy Growth Corporation
Canopy Growth is a world-leading diversified cannabis company, offering distinct brands and curated cannabis varieties in dried, oil and capsule forms. Through its wholly‑owned subsidiaries, Canopy Growth operates numerous state-of-the-art production facilities with over half a million square feet of GMP-certified indoor and greenhouse production capacity, all to an unparalleled level of quality assurance procedures and testing. Canopy Growth has established partnerships with leading sector names in Canada and abroad, with interests and operations spanning four continents. The Company is proudly dedicated to educating healthcare practitioners, providing consistent access to high quality cannabis products, conducting robust clinical research, and furthering the public's understanding of cannabis. For more information visit www.canopygrowth.com
About Green House Holdings North America Inc.
Green House Brands is bringing the most awarded and recognized cannabis brand in the world to the North American market. Established in 1985 in Amsterdam, the Green House Brands portfolio includes five leading marijuana businesses - Strain Hunters, Green House Seed Co., Green House Feeding, Green House Coffee shops & King of Cannabis — as seen on VICE & National Geographic. Green House assets have won the company numerous accolades, including over 40 High Times Cannabis Cups and 200+ awards for top genetics, establishing the company's leadership in the global cannabis industry. Green House was a pioneer in the development of the European cannabis coffee shop market, where its Green House Coffee shops in the Netherlands and Strain Hunters Clubs in Spain remain market leaders. As Strain Hunters, the company has been featured in documentary series on HBO and VICE, highlighting its globetrotting journeys to find the rarest landrace strains of cannabis. Green House and Strain Hunters media has over 150M views and has one of the most powerful marketing platforms in the industry. Green House enters the rapidly developing legal North American cannabis markets with all of its enterprises. For more information please visit www.greenhousebrands.com
About Organa Brands
Organa Brands revolutionized the cannabis industry with the introduction of supercritical CO₂extracted cannabis oil in 2010 and the introduction of the groundbreaking O.penVAPE device in 2012. Today, the company is home to the world's largest consumer cannabis brands. After developing O.penVAPE, Bakked, and Organa Labs into world-class brands with nationwide distribution, the company acquired The Magic Buzz, and entered into a joint venture to form District Edibles. Organa Brands sells one of its products every 4 seconds around the world, and has delivered over one billion puffs through its flagship O.penVAPE line. A brand incubator and pioneer in the cannabis space, Organa Brands utilizes its 12 production facilities in 11 states and Jamaica to manufacture its extensive catalog of products. Organa Brands sells its cannabis products in over 1,200 retail locations with ancillary hardware sold in thousands of retailers globally– making it the largest cannabis-oil-based consumer products company in the United States. Agripharm– a joint venture between Organa Brands, Canopy Growth Corporation (TSX: WEED), and the world-renowned Greenhouse Seed Company– ushers in a new era of international distribution for the three brand powerhouses. Organa Brands is committed to dominating the global cannabis market through the marriage of science and technology, all for the benefit of the consumer. For more information, please visit www.OrganaBrands.com
Notice Regarding Forward Looking Information
This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Canopy Growth, its subsidiaries or the JV to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Examples of such statements include the issuance of additional common shares, the contribution to be made by Green House and Organa Brands, the purchase of cannabis products by Canopy Growth from Agripharm, the Company's expectations about its positioning and branding in the Canadian market, the Company's collaborative efforts with Green House and Organa Brands internationally, and the expansion of the Agripharm facility. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including risks associated with: timelines for expansion, including with respect to construction and Health Canada's approval process; availability of additional financing; third-party and regulatory approvals; and such risks contained in the Company's annual information form dated June 28, 2017 and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this press release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.
SOURCE Canopy Growth Corporation
[Blocked Image: https://rt.newswire.ca/rt.gif?NewsItemId=C7169&Transmission_Id=201711170630CANADANWCANADAPR_C7169&DateId=20171117]
For further information: Canopy Growth Contacts: Jordan Sinclair, Director of Communications, Jordan@canopygrowth.com, 613-769-4196; Investor Relations: Tyler Burns, Tyler.burns@canopygrowth.com, 855-558-9333 ex 122; Organa Brands Contacts: Jackson D. Tilley, Director of Public Relations & Community Affairs, 970-518-6452, Jackson@OrganaBrands.com
Related Links
Ist etwas viel Text und Zahlen, deshalb s. Link: *smile**dirol*
http://www.newswire.ca/news-re…al-markets-657420813.html
Und wie sehen wir das?
Dies mal im Voraus:
Canopy Growth refiles fiscal 2017 results
2017-11-13 20:13 ET - News Release
Mr. Jordan Sinclair reports
CANOPY GROWTH CORPORATION FILES AMENDED AND RESTATED FISCAL YEAR 2017 FINANCIAL RESULTS
Canopy Growth Corp. has filed its amended and restated consolidated financial statements and amended and restated management's discussion and analysis for the year ended March 31, 2017, on SEDAR.
The restatement accounts for:
i) the understated fair value of approximately 11% equity interest and options held by the Company in AusCann Group Holdings Ltd. ("AusCann") by $18.3 million and $5.7 million, respectively, at March 31, 2017 which was previously carried at its cost base of nil being the consideration paid for the minority interest.
The Company has classified its equity interest in AusCann as an available{a ‑}for{a ‑}sale financial asset, an IFRS term. The options represent a derivative financial instrument that is initially recognised at fair value and subsequently remeasured to its fair value at the end of each reporting period. Prior to February 3, 2017 the AusCann shares did not have a quoted market price and the fair value of its equity interest and options in AusCann could not be reliably measured and the equity interest and options were carried at their cost amount of nil.
In the quarter ended March 31, 2017, AusCann completed a capital reorganization and became listed on the Australian Stock Exchange. Following the initial public offering, the Company's shares and options were all placed in escrow until February 3, 2019.
ii) the correction of an immaterial non-cash error in the valuation of biological assets at March 31, 2017, as previously disclosed in the condensed interim consolidated financial statements for the first quarter ended June 30, 2017.
As a result of the restatement, the Company's reported Net Loss was reduced from $16.7 million to a Net Loss of $7.6 million.
Details of the changes are fully described in Note 2 to the Amended and Restated Consolidated Financial Statements for the Year Ended March 31, 2017 as filed on SEDAR on November 13, 2017.
About Canopy Growth Corporation
Canopy Growth is a world-leading diversified cannabis company, offering distinct brands and curated cannabis varieties in dried, oil and capsule forms. Through its wholly‑owned subsidiaries, Canopy Growth operates numerous state-of-the-art production facilities with over half a million square feet of GMP-certified indoor and greenhouse production capacity, all to an unparalleled level of quality assurance procedures and testing. Canopy Growth has established partnerships with leading sector names in Canada and abroad, with interests and operations spanning four continents. The Company is proudly dedicated to educating healthcare practitioners, providing consistent access to high quality cannabis products, conducting robust clinical research, and furthering the public's understanding of cannabis. For more information visi twww.canopygrowth.com.
We seek Safe Harbor.
© 2017 Canjex Publishing Ltd. All rights reserved.
Info: 
Canopy Growth comments on Federal Excise Tax Proposal
News provided by
13:51 ET
SMITHS FALLS, ON, Nov. 10, 2017 /CNW/ - Canopy Growth Corporation (TSX: WEED) ("Canopy Growth" or the "Company") has been a longtime vocal proponent of a fair and reasonable tax rate that funds important programs needed to successfully transition cannabis out of prohibition. To this point, the Company has spent almost $1-million on its core CSR initiatives over the past three years in key policy areas; research, road safety, and youth education, and commits $1 from the sale of every bottle of cannabis oil to education projects.
The Company's efforts include funding for important research initiatives such as the Quebec Cannabis Registry, funding a series of PSAs in partnership with MADD Canada and the Canadian Drug Policy Coalition, and committing funding to Parent Action on Drugs and Canadian Students for Sensible Drug Policy to support cannabis-specific education initiatives designed for parents looking for resources to help them talk to their children about responsible choices.
Today's proposed rate, ten percent on top of existing HST falls within the limit of an acceptable tax framework and is in line with Management's expectation. The proposed rate should allow Canopy Growth and other industry players of various sizes to compete with the black market on price point. Canopy Growth also strongly supports a system that sees the federal and provincial governments collaborate on taxation source and structure. A consistent rate across the country is preferable and would give the Company the confidence it needs to continue creating jobs and investing hundreds of millions of dollars across Canada.
While in some ways the Company understands the policy rationale of including taxation on medical cannabis sales, it is unfortunate that despite Canopy Growth's ongoing advocacy efforts on the subject cannabis will continue to be the only physician-authorized drug in the country subject to sales tax. This is an unfair tax burden on chronically ill Canadians and only further reinforces the need for government, industry and patients to work together to obtain insurance coverage for authorized medical cannabis patients. To that end Canopy Growth is hopeful that revenue from cannabis taxation is earmarked for research to accelerate the Drug Identification Number approval process which is seen as the key to medical insurance coverage for cannabis-based medicines.
Here's to Future Growth.
About Canopy Growth Corporation
Canopy Growth is a world-leading diversified cannabis company, offering distinct brands and curated cannabis varieties in dried, oil and capsule forms. Through its wholly‑owned subsidiaries, Canopy Growth operates numerous state-of-the-art production facilities with over half a million square feet of GMP-certified indoor and greenhouse production capacity, all to an unparalleled level of quality assurance procedures and testing. Canopy Growth has established partnerships with leading sector names in Canada and abroad, with interests and operations spanning four continents. The Company is proudly dedicated to educating healthcare practitioners, providing consistent access to high quality cannabis products, conducting robust clinical research, and furthering the public's understanding of cannabis. For more information visit www.canopygrowth.com.
@ Emil und alle, die hier auf dem Weg sind:
Da darf man auch gespannt sein, auf diesen Zahlen-Temin. Aber nicht nur dies sondern all die grandiosen Meldungen der letzten Tage und Wochen sind zukunftsweisend und Absolut wichtig für die weiteren Prognosen, die sich durch das Bisherige bereits im Vorfeld erahnen lassen.
Da ist doch gleich noch was von heute: *smile* *dirol*
Canopy, Delta 9 cheer Manitoba weed plan
2017-11-08 06:53 ET - News Release
Also News Release (C-NINE) Delta 9 Cannabis Inc
Mr. Mark Zekulin of Canopy reports
DELTA 9 AND CANOPY GROWTH APPLAUD MANITOBA CANNABIS PLAN
Canopy Growth Corp. and Delta 9 Cannabis Inc. applaud the framework today announced by the Province of Manitoba regarding adult-use cannabis production, distribution and retail.
The decision by the government of Manitoba to allow for private retail distribution of cannabis while ensuring that public safety and health concerns are the focal points of its cannabis policies is a strong and welcomed approach. As responsible existing cannabis businesses, Delta 9 and Canopy Growth plan to work collaboratively within the proposed Manitoba framework to bring locally produced products as well as the best variety from across the country to future cannabis consumers throughout the province.
The companies submitted a collaborative expression of interest in July, 2017, outlining their proposed participation in the Manitoba market including production and distribution functions with both companies pursuing privately owned and operated retail.
"As provinces continue to roll out distribution and retail strategies we are starting to gain a clearer understanding of our operational needs leading into next year," said Mark Zekulin, president, Canopy Growth.
"Manitoba has signalled an openness to private retail operations, and as responsible private companies already meeting the strict regulations for the production and sale of medical cannabis across the country, we believe our track record positions us well to satisfy the government's objectives while meeting the needs of Manitoba consumers. We are proud to partner with a respected, responsible local Manitoba company in Delta 9 to bring our offering forward."
While working together in Manitoba, Delta 9 has also entered into a distribution arrangement with Canopy Growth that will allow Delta 9 to expand its retail presence outside the province as Canopy pursues distribution deals similar to the agreement it entered with the Province of New Brunswick in September, 2017, to bring the highest-quality and best variety of products to consumers across the country.
"As a cannabis producer headquartered in Winnipeg, our team is very pleased at the prospect of expanding our operations to include physical locations in addition to our existing e-commerce solution," said Delta 9 co-founder and chief executive officer John Arbuthnot.
About Delta 9 Cannabis Inc.
Delta 9's wholly owned subsidiary, Delta 9 Bio-Tech, is a licensed producer of medical marijuana pursuant to Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR) and operates an 80,000-square-foot, expandable, state-of-the-art production facility in Winnipeg, Man., Canada.
We seek Safe Harbor.
© 2017 Canjex Publishing Ltd. All rights reserved.
Danke für die Terminangabe, hier kommen fast täglich gute Meldungen rüber:
Canopy completes $245M share issuance to Constellation
2017-11-02 09:05 ET - News Release
Mr. Bruce Linton reports
CANOPY GROWTH AND CONSTELLATION FINALIZE PREVIOUSLY ANNOUNCED STRATEGIC TRANSACTION
Canopy Growth Corp. has completed the previously announced transaction that saw Constellation Brands strategically invest $245-million in Canopy Growth in exchange for 9.9-per-cent equity in the company following completion of the investment. As a result, the company has today issued 18,876,901 common shares in the company to an affiliate of Constellation in exchange for $244,990,084.25.
In addition, the company also issued 18,876,901 warrants to the Constellation affiliate as part of this investment.
Management looks forward to a long and productive collaborative relationship with Constellation.
Here's to future growth.
About Canopy Growth Corp.
Canopy Growth is a world-leading diversified cannabis company, offering distinct brands and curated cannabis varieties in dried, oil and capsule forms. Through its wholly owned subsidiaries, Canopy Growth operates numerous state-of-the-art production facilities with over half a million square feet of GMP-certified indoor and greenhouse production capacity, all to an unparalleled level of quality assurance procedures and testing. Canopy Growth has established partnerships with leading sector names in Canada and abroad, with interests and operations spanning four continents.
We seek Safe Harbor.
© 2017 Canjex Publishing Ltd. All rights reserved.
Gestern:
Canopy Growth adds to strategic content & branding prowess by adding Ted Chung & Dave Bigioni to key roles
News provided by
Nov 01, 2017, 07:00 ET
Share this article
SMITHS FALLS, ON, Nov. 1, 2017 /CNW/ - Canopy Growth Corporation (TSX: WEED) ("Canopy Growth" or the "Company") today announced that it has welcomed the founder of Stampede Management, Ted Chung, as a Strategic Advisor for Content Strategy to strengthen and leverage responsible brand opportunities for Tweed and other cannabis brands in the lead-up to the legal adult-use market in Canada.
Mr. Chung has established himself as a thought leader and visionary in the cannabis media landscape as, among many notable accomplishments, a founder of MERRY JANE and an Executive Producer on the EMMY-Nominated television series Martha and Snoop's Potluck Dinner Party. Ted is also the longtime manager of cultural icon Snoop Dogg.
Ted's joining builds upon the recent hiring of Dave Bigioni as the Chief Marketing Officer for all Canopy Growth brands. Mr. Bigioni joined the Company in August from an executive role at Molson Coors Brewing Company where he spent nine years in sales and marketing functions building one of Canada's iconic beer brands.
Canopy Growth's leadership team has developed a collaborative working relationship with Mr. Chung highlighted by the partnership established with Leafs By Snoop in Canada in 2016.
"I want to personally welcome Ted and Dave to the Canopy family," said Mark Zekulin, President, Canopy Growth. "In a competitive media landscape that rewards innovative approaches to responsible education and awareness, they have proven their ability to create stories and moments that resonate with people. I look forward to collaborating with them and bringing the exciting story about the people, products and vision of Tweed and all Canopy brands to life."
"Canopy Growth and Tweed are progressive leaders across the board for our industry. I look forward to creating a content strategy that is thoughtful of where cannabis business is today and valuable to how cannabis culture is adopted by the mainstream within a year," commented Ted Chung.
Here's to Future Growth.
About Tweed
Tweed is a globally recognized cannabis production brand. It has built a large and loyal following by focusing on quality products and meaningful customer relationships. Tweed doesn't just sell cannabis, it facilitates a conversation about a product we've all heard about but haven't met intimately yet. It is approachable and friendly, yet reliable and trusted. As cannabis laws liberalize around the world, Tweed will expand its leading Canadian position around the globe. Learn more at www.tweed.com.
About Canopy Growth Corporation
Canopy Growth is a world-leading diversified cannabis company, offering distinct brands and curated cannabis varieties in dried, oil and capsule forms. Through its wholly‑owned subsidiaries, Canopy Growth operates numerous state-of-the-art production facilities with over half a million square feet of GMP-certified indoor and greenhouse production capacity, all to an unparalleled level of quality assurance procedures and testing. Canopy Growth has established partnerships with leading sector names in Canada and abroad, with interests and operations spanning four continents. The Company is proudly dedicated to educating healthcare practitioners, providing consistent access to high quality cannabis products, conducting robust clinical research, and furthering the public's understanding of cannabis. For more information visit www.canopygrowth.com.
Nun ja, der Kurs ist explodiert, + 19%. Freu... ob es hält?
Zahlen sollten hier am 30.11.2017 rauskommen.
Scheint eine absolute Top-Leistung zu sein:
6.10.2017 | 23:21
TEMPE (dpa-AFX) - First Solar, Inc. (FSLR) reported a profit for its third quarter that rose from last year.
The company said its bottom line advanced to $0.21 billion, or $1.95 per share. This was higher than $0.15 billion, or $1.45 per share, in last year's third quarter.
The company said revenue for the quarter rose 60.3% to $1.09 billion. This was up from $0.68 billion last year.
First Solar, Inc. earnings at a glance:
-Earnings (Q3): $0.21 Bln. vs. $0.15 Bln. last year. -Earnings Growth (Y-o-Y): 40.0% -EPS (Q3): $1.95 vs. $1.45 last year. -EPS Growth (Y-o-Y): 34.5% -Revenue (Q3): $1.09 Bln vs. $0.68 Bln last year. -Revenue Change (Y-o-Y): 60.3%
-Guidance: Full year EPS guidance: $2.05 - $2.30 Full year revenue guidance: $3.0 - $3.1 Bln
Copyright RTT News/dpa-AFX
© 2017 AFX News
Weiteres:
Hier bei CGC (WEED) ist in den letzen Septembertagen auch noch einiges gelaufen, das positiv war. Allerdings war ich teilweise auch etwas weg und habe nicht alles gepostet hier. Man kann aber nachlesen auf der Homepage..
Hier noch eine interessante Analyse, etwas lang, deshalb s. Link:
Emil, wünsche weiterhin gute Tage. Dazu noch von heute Abend:
Find ich einfach köstlich: *pleasantry* *biggrin* *dirol*
US-Außenminister Tillerson dementiert Rücktrittsgedanken
Wirbel um US-Außenminister Rex Tillerson: Der mehrfach von Donald Trump brüskierte US-Außenminister soll laut einem Medienbericht den Präsidenten hinter verschlossenen Türen als "Deppen" beschimpft und im Sommer kurz vor dem Rücktritt gestanden haben. Wie der Fernsehsender NBC News unter Berufung auf "hochrangige Regierungsmitarbeiter" berichtete, soll Tillerson die Beschimpfung des Präsidenten bei einem Treffen im Pentagon am 20. Juli ausgestoßen haben.
Ja, das denke ich auch. Hier noch von heute Morgen:
News:
SMITHS FALLS, ON and FREDERICTON, Sept. 15, 2017 /CNW/ - Canopy Growth Corporation (TSX: WEED) ("Canopy Growth" or the "Company") and the Province of New Brunswick today announced a significant milestone in the history of Canadian cannabis, whereby the Government of New Brunswick, through a newly created provincial authority and Canopy Growth, the largest licensed producer of regulated cannabis in the world, have entered into a supply Memorandum of Understanding (MOU) to guarantee a reliable and high-quality supply of cannabis products into New Brunswick's retail stores that will flow from a crown corporation newly formed by the province of New Brunswick.
As one of the first MOUs between a licensed cannabis producer and a provincial body for cannabis supply for the retail environment, this is a concrete step towards the federally targeted date of July 2018 for legalization of recreational-use cannabis. Canopy Growth is excited, along with fellow producer Organigram, to be a part of this landmark moment, and commends the leadership shown by the Province of New Brunswick as it moves proactively to ensure its supply needs are met for the anticipated adult-use cannabis market.
The two-year supply agreement, including 4,000,000 grams of cannabis and cannabis derivative products for the first year, is expected to have an estimated retail value of $40 million in its first year.
"New Brunswick has led the country in its efforts to attract cannabis jobs and investment and Canopy Growth is proud to be utilizing local trades and to hire in New Brunswick for the site we are establishing in Fredericton," said Mark Zekulin, President, Canopy Growth. "Today we take the next step towards the future of cannabis in New Brunswick with a truly historic MOU. We are excited to bring high quality brands like Tweed, Leafs By Snoop, DNA Genetics, as well as a number of the best independent craft grow cannabis producers across Canada to the people of New Brunswick through this arrangement."
Based on production capabilities across the Canopy-wide production platform, this agreement will not affect medical sales or our commitment to meeting the needs of Canadians who require cannabis for medical purposes.
Staying true to its longstanding commitment to Corporate Social Responsibility, including partnerships with MADD Canada, the Canadian AIDS Society, Parent Action on Drugs, and a commitment to contribute funds from all online cannabis oil sales to education, Canopy Growth will proudly remit a monetary amount equal to two per cent of the gross value of all cannabis products sold to the government annually for social and/or educational programs.
Here's to (Firsts, and) Future Growth.
About Tweed
Tweed is a globally recognized marijuana production brand. It has built a large and loyal following by focusing on quality products and meaningful customer relationships. Tweed doesn't just sell marijuana, it facilitates a conversation about a product we've all heard about but haven't met intimately yet. It is approachable and friendly, yet reliable and trusted. As marijuana laws liberalize around the world, Tweed will expand its leading Canadian position around the globe. Learn more at www.tweed.com.
About Canopy Growth Corporation
Canopy Growth is a world-leading diversified cannabis company, offering distinct brands and curated cannabis varieties in dried, oil and capsule forms. Through its wholly‑owned subsidiaries, Canopy Growth operates numerous state-of-the-art production facilities with over half a million square feet of GMP-certified indoor and greenhouse production capacity, all to an unparalleled level of quality assurance procedures and testing. Canopy Growth has established partnerships with leading sector names in Canada and abroad, with interests and operations spanning four continents. The Company is proudly dedicated to educating healthcare practitioners, providing consistent access to high quality cannabis products, conducting robust clinical research, and furthering the public's understanding of cannabis. For more information visit www.canopygrowth.com.
Notice Regarding Forward Looking Statements
This news release contains forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Canopy Growth Corporation, Tweed Inc., Tweed Farms Inc., Mettrum Health Corp., or Bedrocan Canada Inc. to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Examples of such statements include future operational and production capacity, the impact of enhanced infrastructure and production capabilities, and forecasted available product selection. The forward-looking statements included in this news release are made as of the date of this news release and Canopy Growth Corp. does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.
Neither the TSX Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE Canopy Growth Corporation [Blocked Image: https://rt.newswire.ca/rt.gif?NewsItemId=C4914&Transmission_Id=201709150730CANADANWCANADAPR_C4914&DateId=20170915]
For further information: Jordan Sinclair, Director of Communications, Jordan@canopygrowth.com, 613-769-4196, @CanopyGrowth; Investor Relations, Tyler Burns, Tyler.burns@canopygrowth.com, 855-558-9333 ex 122; Director: Bruce Linton, tmx@canopygrowth.com
RELATED LINKS
http://canopygrowth.com/
